The choice whether to start therapy early, while an individual is still asymptomatic, versus delaying therapy until clinical or immunologic symptoms appear, continues to generate considerable controversy among pediatric and adult HIV experts [82]. Some experts favor starting aggressive therapy in the early stages of HIV infection in the hope that early antiretroviral intervention will control viral replication prior to the onset of rapid genetic mutation and evolution into multiple quasispecies.